跳至主要内容
临床试验/IRCT20230228057568N1
IRCT20230228057568N1尚未招募3 期

Comparison of the Effectiveness of noradrenaline with the combination of octreotide and midodrine in the treatment of hepatorenal syndrome type 1

Gorgan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Diagnosis based on modified HRS diagnostic criteria in 2007: Cirrhosis with ascites and increased serum creatinine level (>1.5 mg/dL) with non-recovery up to 48 hours after diuretic discontinuation and volume increase with albumin
  • Absence of shock
  • Not receiving nephrotoxic drugs
  • Absence of kidney parenchymal disease or obstructive uropathy in laboratory and ultrasound assessment
  • Doubling of creatinine level to more than 2.5 mg/dL in 2 weeks or less

排除标准

  • History of coronary disease and evidence of ventricular arrhythmia or cardiomyopathy obtained based on history taking, assessment of risk factors, physical examination, echocardiography and radiography.

研究者

发起方
Gorgan University of Medical Sciences

相似试验